Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients With Chronic Low Back Pain (ShockEffect)

November 21, 2023 updated by: Dr. med. Tobias Lange, MBA, Ruhr University of Bochum

Effectiveness of Radial Extracorporeal Shockwave Therapy in Patients With Chronic Low Back Pain - Randomized Controlled Trial

Analysis of the effectiveness of radial shock wave therapy as part of a multimodal pain therapy in the inpatient setting. Different therapy protocols are compared in previously non-operated and in previously operated patients.

Study Overview

Detailed Description

Radial shock wave therapy is an approved pain therapy procedure that has been used in various degenerative orthopedic diseases for years. There are a few studies on the subject of chronic back pain. Some studies suggest that this method can be used sensibly. A direct comparison of different therapy protocols has not been carried out so far.

As part of inpatient multimodal pain therapy (including infiltration and physiotherapy) in patients with chronic lumbar back pain with or without degenerative surgery in the area of the lumbar spine radial shock wave therapy after a specific protocol is used. Only inpatients will be admitted to the study. All patients are informed verbally and give their written consent. Comprehensive patient information will be provided before the start of the study, handed out and explained as part of the information discussion. There will be 2 groups ((a) patients with previous degenerative surgery in the area of the lumbar spine, (b) patients without such a pre-operation) examined each with 4 sub-groups depending of the different therapy protocols.

Study Type

Interventional

Enrollment (Estimated)

400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Hattingen, Germany, 45527
        • Recruiting
        • Klinik Blankenstein
        • Contact:
          • Sylvia Schreyer, MD
        • Principal Investigator:
          • Sylvia Schreyer, MD
        • Principal Investigator:
          • Tayna Greiling

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • chronic lumbar back pain of min 3 months duration

Exclusion Criteria:

  • radicular pain of higher intensity than chronic low back pain (cLBP)
  • new neurologic deficits
  • anticoagulant therapy
  • new trauma to the lumbar spine
  • spine bacterial infection
  • spine tumor
  • pregnancy
  • coagulation disorder
  • previous infiltration to the lumbar spine within 6 weeks prior to study inclusion
  • fibromyalgia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: PreviousSurgery(PrevSurg)_YES/rESWT_4000
Previous Surgery on degenerative pathology in lumbar spine: YES rESWT: 4000 pulse, 20 Hz
application of radial extracorporeal shockwave therapy (rESWT) with 4000 pulses and 20 Hz
standard multimodal pain therapy
Active Comparator: PrevSurg_YES/rESWT_500
Previous Surgery on degenerative pathology in lumbar spine: YES rESWT: 500 pulse, 2 Hz
standard multimodal pain therapy
application of radial extracorporeal shockwave therapy (rESWT) with 500 pulses and 2 Hz
Active Comparator: PrevSurg_YES/rESWT_no
Previous Surgery on degenerative pathology in lumbar spine: YES rESWT: no
standard multimodal pain therapy
Active Comparator: PrevSurg_YES/rESWT_deny
Previous Surgery on degenerative pathology in lumbar spine: YES rESWT: denied
standard multimodal pain therapy
Active Comparator: PrevSurg_NO/rESWT_4000
Previous Surgery on degenerative pathology in lumbar spine: NO rESWT: 4000 pulse, 20 Hz
application of radial extracorporeal shockwave therapy (rESWT) with 4000 pulses and 20 Hz
standard multimodal pain therapy
Active Comparator: PrevSurg_NO/rESWT_500
Previous Surgery on degenerative pathology in lumbar spine: NO rESWT: 500 pulse, 2 Hz
standard multimodal pain therapy
application of radial extracorporeal shockwave therapy (rESWT) with 500 pulses and 2 Hz
Active Comparator: PrevSurg_NO/rESWT_no
Previous Surgery on degenerative pathology in lumbar spine: NO rESWT: no
standard multimodal pain therapy
Active Comparator: PrevSurg_NO/rESWT_deny
Previous Surgery on degenerative pathology in lumbar spine: NO rESWT: denied
standard multimodal pain therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in Numeric Rating Scale (NRS)
Time Frame: pre-intervention, 2 weeks, 1 month, 3 months, 6 months

Pain intensity measured by Numeric Rating Scale (NRS)

- 11-point scale / min. 0 (better outcome) / max. 10 (worse outcome)

pre-intervention, 2 weeks, 1 month, 3 months, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in Oswestry Disability Index (ODI)
Time Frame: pre-intervention, 2 weeks, 1 month, 3 months, 6 months
Oswestry Disability Index (ODI)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months
change in European Quality of Life 5 Dimensions (EQ5D)
Time Frame: pre-intervention, 2 weeks, 1 month, 3 months, 6 months
European Quality of Life 5 Dimensions (EQ5D)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months
change in Pain Self-Efficacy Questionnaire (PSEQ)
Time Frame: pre-intervention, 2 weeks, 1 month, 3 months, 6 months
Pain Self-Efficacy Questionnaire (PSEQ)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months
change in Patient Health Questionnaire-9 (PHQ-9)
Time Frame: pre-intervention, 2 weeks, 1 month, 3 months, 6 months
Patient Health Questionnaire-9 (PHQ-9)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months
change in Perseverative Thinking Questionnaire (PTQ)
Time Frame: pre-intervention, 2 weeks, 1 month, 3 months, 6 months
Perseverative Thinking Questionnaire (PTQ)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months
change in Patient Specific Functional Scale (PSFS)
Time Frame: pre-intervention, 2 weeks, 1 month, 3 months, 6 months

Patient Specific Functional Scale (PSFS)

  • five daily important activities are rated on a 11-point scale
  • min. 0 (worse outcome) / max. 10 (better outcome)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months
change in The World Health Organisation- Five Well-Being Index (WHO-5)
Time Frame: pre-intervention, 2 weeks, 1 month, 3 months, 6 months
The World Health Organisation- Five Well-Being Index (WHO-5)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months
change in Big Five Inventory-SocioOeconomicPanel (BFI-S)
Time Frame: pre-intervention, 2 weeks, 1 month, 3 months, 6 months
Big Five Inventory-SocioOeconomicPanel (BFI-S)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months
change in Questionnaire Subgroups for Targeted Treatment (STarT-G)
Time Frame: pre-intervention, 2 weeks, 1 month, 3 months, 6 months
Subgroups for Targeted Treatment (STarT-G)
pre-intervention, 2 weeks, 1 month, 3 months, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Tobias L Schulte, Prof, Department of Orthopaedics and Trauma Surgery, St. Josef-Hospital, Ruhr-University Bochum

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 18, 2022

Primary Completion (Estimated)

April 30, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

March 15, 2022

First Submitted That Met QC Criteria

March 24, 2022

First Posted (Actual)

April 4, 2022

Study Record Updates

Last Update Posted (Actual)

November 22, 2023

Last Update Submitted That Met QC Criteria

November 21, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1_1

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low-back Pain (cLBP)

Clinical Trials on radial extracorporeal shockwave therapy_4000_20

3
Subscribe